ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,972,557 | +0.3% | 598,100 | -0.3% | 0.01% | +71.4% |
| Q1 2023 | $2,964,267 | -20.0% | 600,054 | +1.8% | 0.01% | -70.8% |
| Q4 2022 | $3,706,408 | -45.6% | 589,254 | -6.5% | 0.02% | -70.7% |
| Q3 2022 | $6,808,000 | -0.6% | 630,425 | +4.9% | 0.08% | +7.9% |
| Q2 2022 | $6,851,000 | +7.3% | 601,014 | -14.3% | 0.08% | -23.2% |
| Q1 2022 | $6,387,000 | -39.1% | 701,053 | -0.3% | 0.10% | -38.1% |
| Q4 2021 | $10,495,000 | +2.6% | 703,386 | +76.7% | 0.16% | -28.9% |
| Q3 2021 | $10,230,000 | -2.0% | 398,052 | -0.5% | 0.22% | -1.3% |
| Q2 2021 | $10,436,000 | -26.4% | 400,152 | -0.4% | 0.23% | -32.3% |
| Q1 2021 | $14,177,000 | – | 401,602 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |